TrialPanorama/TrialPanorama-database huggingface dataset:
Study 16062074 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 11863244 — Surrogate Endpoint (SUR): Blood pressure
Study 21977965 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 14638387 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 10883875 — Surrogate Endpoint (SUR): Probing pocket depth
Study 25038148 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12392343 — Surrogate Endpoint (SUR): Blood pressure
Study 7503851 — Surrogate Endpoint (SUR): Blood pressure
Study 30599109 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29030584 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 14686964 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 14686964 — Surrogate Endpoint (SUR): Blood pressure
Study 7818958 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15812253 — Surrogate Endpoint (SUR): Blood pressure
Study 8576810 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 999987 — Surrogate Endpoint (SUR): Blood pressure
Study 30531488 — Surrogate Endpoint (SUR): Blood pressure
Study 28419206 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31519167 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 19464413 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 31900758 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28615356 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study 26179616 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 10770346 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28785986 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 26112745 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19273782 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 28945992 — Safety Biomarker (SAF): miR-192
Genes: MIR192
Study 25759545 — Monitoring Biomarker (MOI): HBV DNA
Study 19127598 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 19127598 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study 19127598 — Safety Biomarker (SAF): Cyclin-dependent kinase inhibitor 1
Genes: CDKN1A
Study 17455121 — Surrogate Endpoint (SUR): Blood pressure
Study 10220834 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 28425312 — Predictive Biomarker (PRD): SLC12A5 mRNA
Genes: SLC12A5; KCC2; KIAA1176
Study 28425312 — Safety Biomarker (SAF): BDNF
Study 28425312 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 25824475 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25824475 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 25824475 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25824475 — Predictive Biomarker (PRD): MMP2 mRNA
Genes: MMP2; CLG4A
Study 25824475 — Predictive Biomarker (PRD): TIMP2 mRNA
Genes: TIMP2
Study 25824475 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 24233255 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22660441 — Surrogate Endpoint (SUR): Blood pressure
Study 11401117 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 11401117 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 31654782 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 28372680 — Surrogate Endpoint (SUR): Serum sodium
Study 26148612 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 8124838 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8124838 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26727743 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 25660340 — Predictive Biomarker (PRD): NES mRNA
Genes: NES; Nbla00170
Study 19253084 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17091205 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 11318841 — Predictive Biomarker (PRD): ABCC8 mRNA
Genes: ABCC8; HRINS; SUR; SUR1
Study 9597863 — Surrogate Endpoint (SUR): Bacterial count
Study 7940731 — Predictive Biomarker (PRD): CD6 mRNA
Genes: CD6
Study 25704020 — Surrogate Endpoint (SUR): Blood pressure
Study 25704020 — Surrogate Endpoint (SUR): Serum creatinine
Study 21628666 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17986327 — Surrogate Endpoint (SUR): Blood pressure
Study 9020492 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 7885970 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30212239 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 26071277 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 22610907 — Surrogate Endpoint (SUR): Blood pressure
Study 18831711 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 12034149 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 28865897 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 18928089 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 10781473 — Surrogate Endpoint (SUR): Blood pressure
Study 11064438 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 1290245 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1290245 — Surrogate Endpoint (SUR): Blood pressure
Study 30501620 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 11247166 — Surrogate Endpoint (SUR): Blood pressure
Study 8751516 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 15632536 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 12383453 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 10215955 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 24799074 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 24799074 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study 3209284 — Surrogate Endpoint (SUR): Blood pressure
Study 28409385 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 28409385 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 28409385 — Predictive Biomarker (PRD): HSPD1 mRNA
Genes: HSPD1; HSP60
Study 28409385 — Monitoring Biomarker (MOI): Complement C4
Study 28409385 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 23579349 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30431520 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 24554005 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 12802000 — Surrogate Endpoint (SUR): Forced vital capacity
Study 17433840 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 17433840 — Surrogate Endpoint (SUR): Blood pressure
Study 14870620 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11572739 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24635772 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 14604304 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8831988 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 8831988 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 19092122 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 12915774 — Surrogate Endpoint (SUR): Serum calcium
Study 9366940 — Surrogate Endpoint (SUR): Blood pressure
Study 31941353 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31941353 — Surrogate Endpoint (SUR): Blood pressure
Study 22032706 — Surrogate Endpoint (SUR): Serum potassium
Study 17138063 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study 14633147 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 30785851 — Predictive Biomarker (PRD): DPT mRNA
Genes: DPT
Study 31762390 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 24189760 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24189760 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17200316 — Surrogate Endpoint (SUR): Bone mineral density
Study 3860035 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 23818351 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 23818351 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 23818351 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 8771007 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30044162 — Surrogate Endpoint (SUR): Serum testosterone
Study 30044162 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11892710 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 11113693 — Surrogate Endpoint (SUR): Blood pressure
Study 24020449 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study 12589361 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 25350973 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11157558 — Predictive Biomarker (PRD): MAP3K10 mRNA
Genes: MAP3K10; MLK2; MST
Study 189326 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 25596659 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 15150204 — Surrogate Endpoint (SUR): Serum creatinine
Study 28314552 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 16562684 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 16562684 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 26198928 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 16131531 — Surrogate Endpoint (SUR): Blood pressure
Study 14571607 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 3792351 — Surrogate Endpoint (SUR): Blood pressure
Study 8623168 — Surrogate Endpoint (SUR): Serum creatinine
Study 6126894 — Surrogate Endpoint (SUR): Blood pressure
Study 29244251 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 25833778 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 15079003 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study 31270082 — Predictive Biomarker (PRD): FCGR2C mRNA
Genes: FCGR2C; CD32; FCG2; IGFR2
Study 31270082 — Predictive Biomarker (PRD): FCGR2A mRNA
Genes: FCGR2A; CD32; FCG2; FCGR2A1; IGFR2
Study 31270082 — Predictive Biomarker (PRD): FCGR2B mRNA
Genes: FCGR2B; CD32; FCG2; IGFR2
Study 31270082 — Predictive Biomarker (PRD): FCGR3B mRNA
Genes: FCGR3B; CD16B; FCG3; FCGR3; IGFR3
Study 21793716 — Surrogate Endpoint (SUR): Forced vital capacity
Study 18615480 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 1377295 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 30737332 — Surrogate Endpoint (SUR): Blood pressure
Study 12133500 — Monitoring Biomarker (MOI): HBV DNA
Study 7575719 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7233157 — Surrogate Endpoint (SUR): Blood pressure
Study 29958037 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study 25132608 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 25132608 — Predictive Biomarker (PRD): NELFE mRNA
Genes: NELFE; RD; RDBP
Study 19129748 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 11158017 — Predictive Biomarker (PRD): CPA1 mRNA
Genes: CPA1; CPA
Study 29980042 — Surrogate Endpoint (SUR): Blood pressure
Study 28211169 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 7988012 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7988012 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 31058633 — Surrogate Endpoint (SUR): Bacterial count
Study 11589843 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11589843 — Surrogate Endpoint (SUR): Blood pressure
Study 31745043 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20965956 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 20965956 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17129547 — Monitoring Biomarker (MOI): HBV DNA
Study 15361771 — Surrogate Endpoint (SUR): Blood pressure
Study 22658300 — Surrogate Endpoint (SUR): Blood pressure
Study 22658300 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18178395 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23387245 — Surrogate Endpoint (SUR): Blood pressure
Study 12634885 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 29212987 — Surrogate Endpoint (SUR): Blood pressure
Study 23782594 — Surrogate Endpoint (SUR): Serum creatinine
Study 11383378 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20922265 — Surrogate Endpoint (SUR): Blood pressure
Study 1306536 — Surrogate Endpoint (SUR): Blood pressure
Study 24882173 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 24882173 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24882173 — Safety Biomarker (SAF): BDNF
Study 24882173 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 20060081 — Surrogate Endpoint (SUR): Bone mineral density
Study 2908720 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 2908720 — Surrogate Endpoint (SUR): Blood pressure
Study 30787294 — Predictive Biomarker (PRD): IRF7 mRNA
Genes: IRF7
Study 12428086 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 8578993 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study 365543 — Surrogate Endpoint (SUR): Blood pressure
Study 7237896 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31507249 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 24370353 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 21776573 — Surrogate Endpoint (SUR): Bone mineral density
Study 31255371 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 31255371 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31074184 — Surrogate Endpoint (SUR): Serum sodium
Study 31074184 — Surrogate Endpoint (SUR): Serum creatinine
Study 31074184 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 16962106 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 16962106 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 9892475 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9892475 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 30412606 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30412606 — Surrogate Endpoint (SUR): Blood pressure
Study 25648738 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25648738 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 16202045 — Safety Biomarker (SAF): Vitamin K-dependent protein C
Genes: PROC
Study 6754512 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 6754512 — Predictive Biomarker (PRD): SERPINA7 mRNA
Genes: SERPINA7; TBG
Study 6754512 — Predictive Biomarker (PRD): SERPINA6 mRNA
Genes: SERPINA6; CBG
Study 31609865 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 26837474 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 26837474 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 24638003 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 24638003 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study 22431864 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16277693 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16277693 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30927036 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25791068 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 23980091 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 18339031 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 27536454 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 22580856 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16156881 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12360161 — Surrogate Endpoint (SUR): Blood pressure
Study 11315997 — Surrogate Endpoint (SUR): Bone mineral density
Study 7696164 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 23786655 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 19287305 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 12445377 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 9704757 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 9704757 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9704757 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 2564458 — Surrogate Endpoint (SUR): Platelet count response
Study 22303583 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22303583 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22303583 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24762108 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 9803800 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 31169862 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31169862 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31912632 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 31912632 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 31912632 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30321476 — Predictive Biomarker (PRD): RXRA mRNA
Genes: RXRA; NR2B1
Study 23336505 — Surrogate Endpoint (SUR): Blood pressure
Study 17380681 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 17380681 — Surrogate Endpoint (SUR): Blood pressure
Study 7975845 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 31913830 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 28476553 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 28476553 — Surrogate Endpoint (SUR): Blood pressure
Study 10368454 — Surrogate Endpoint (SUR): Serum calcium
Study 21118681 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21118681 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 21118681 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 8348281 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18543329 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 8917229 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 25800784 — Monitoring Biomarker (MOI): HBV DNA
Study 18309485 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 17035614 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 17035614 — Surrogate Endpoint (SUR): Bone mineral density
Study 30886933 — Surrogate Endpoint (SUR): Blood pressure
Study 20167476 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 18716314 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study 10550150 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 7770260 — Surrogate Endpoint (SUR): Blood pressure